Latest news with #CRADA
Associated Press
08-05-2025
- Business
- Associated Press
Radia and U.S. Department of Defense Collaborate to Assess Utility of WindRunner™, the World's Largest Aircraft, for Dual Use Civil-Military Oversized/Outsized Cargo Operations
BOULDER, Colo., May 8, 2025 /PRNewswire/ -- Radia, the developer of a transformational outsized, high-volume cargo aircraft, the WindRunner™, today announced a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Defense (DoD). With a length of 356 feet (109m) and a wingspan of 261 feet (80m), the WindRunner will have twelve times the volume of the 747 and the ability to land on short and unpaved runways. The CRADA, a research partnership between Radia and U.S. Transportation Command (USTRANSCOM), will focus on understanding the feasibility and operational effectiveness of the WindRunner as a potential commercial carrier option to support critical DoD logistics and transportation needs, such as through the Civil Reserve Air Fleet (CRAF). The agreement allows Radia and DoD to assess how the unique capabilities of the WindRunner allow moving critical military-unique cargo—and to serve the broader civil/ military oversized cargo market. Key areas of research under the CRADA will include: 'The WindRunner allows the world's biggest things to be delivered to the hardest-to-reach locations. This collaboration demonstrates how commercial capabilities may help to support U.S. national defense by integrating with and addressing military needs,' said Mark Lundstrom, Radia Founder and CEO. 'By leveraging the unique design and capabilities of the WindRunner, we can together explore innovative solutions for transporting outsized and high-volume cargo, enhancing the DoD's ability to respond to global challenges.' The CRADA enables joint research efforts, data sharing, and collaboration between Radia and DoD experts. Findings from this research will inform future strategy decisions and operational planning for dual-use civilian and military airlift capabilities. About Radia Radia has developed the WindRunner™, the largest aircraft ever built by volume. Designed for dual use, it enables efficient delivery of oversized cargo to locations with limited infrastructure—serving applications in clean energy, defense, aerospace, and emergency response. In the renewable sector, WindRunner allows the deployment of next-generation onshore wind turbines too large for land transport, unlocking cheaper and more abundant energy. Radia has been recognized by the World Economic Forum as a 'WEF Unicorn' and by Endeavor as an 'Endeavor Entrepreneur.' Learn more at Contact: Kathy Van Buskirk Head of Marketing & Communications, Radia [email protected] +1 720 771 7651 View original content to download multimedia: SOURCE Radia
Malaysian Reserve
08-05-2025
- Business
- Malaysian Reserve
Radia and U.S. Department of Defense Collaborate to Assess Utility of WindRunner™, the World's Largest Aircraft, for Dual Use Civil-Military Oversized/Outsized Cargo Operations
BOULDER, Colo., May 8, 2025 /PRNewswire/ — Radia, the developer of a transformational outsized, high-volume cargo aircraft, the WindRunner™, today announced a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Defense (DoD). With a length of 356 feet (109m) and a wingspan of 261 feet (80m), the WindRunner will have twelve times the volume of the 747 and the ability to land on short and unpaved runways. The CRADA, a research partnership between Radia and U.S. Transportation Command (USTRANSCOM), will focus on understanding the feasibility and operational effectiveness of the WindRunner as a potential commercial carrier option to support critical DoD logistics and transportation needs, such as through the Civil Reserve Air Fleet (CRAF). The agreement allows Radia and DoD to assess how the unique capabilities of the WindRunner allow moving critical military-unique cargo—and to serve the broader civil/ military oversized cargo market. Key areas of research under the CRADA will include: Cargo capacity and handling: Analyzing the WindRunner's ability to transport various types of DoD cargo, including space launch materials, oversized equipment, and humanitarian aid. Ground operations: Evaluating airfield suitability, ground handling procedures, and necessary infrastructure for efficient WindRunner operations. Operational planning: Developing mission profiles and assessing the aircraft's performance in different operational scenarios. Integration with existing DoD systems: Exploring the portions of typical DoD logistics networks that may best be served by the WindRunner commercial cargo option. 'The WindRunner allows the world's biggest things to be delivered to the hardest-to-reach locations. This collaboration demonstrates how commercial capabilities may help to support U.S. national defense by integrating with and addressing military needs,' said Mark Lundstrom, Radia Founder and CEO. 'By leveraging the unique design and capabilities of the WindRunner, we can together explore innovative solutions for transporting outsized and high-volume cargo, enhancing the DoD's ability to respond to global challenges.' The CRADA enables joint research efforts, data sharing, and collaboration between Radia and DoD experts. Findings from this research will inform future strategy decisions and operational planning for dual-use civilian and military airlift capabilities. About Radia Radia has developed the WindRunner™, the largest aircraft ever built by volume. Designed for dual use, it enables efficient delivery of oversized cargo to locations with limited infrastructure—serving applications in clean energy, defense, aerospace, and emergency response. In the renewable sector, WindRunner allows the deployment of next-generation onshore wind turbines too large for land transport, unlocking cheaper and more abundant energy. Radia has been recognized by the World Economic Forum as a 'WEF Unicorn' and by Endeavor as an 'Endeavor Entrepreneur.' Learn more at Contact: Kathy Van Buskirk Head of Marketing & Communications, Radia Kathy@ +1 720 771 7651
Yahoo
22-04-2025
- Business
- Yahoo
SMSbiotech Establishes a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Chemical Defense
SAN MARCOS, Calif., April 22, 2025--(BUSINESS WIRE)--SMSbiotech, Inc. is pleased to announce the signing of a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). This is the first CRADA agreement for SMSbiotech, and it represents a significant milestone in the company's efforts to address critical military and civilian medical challenges that have existed for over a century. Under this agreement, SMSbiotech and USAMRICD will conduct joint research focused on evaluating the efficacy of SMS cells in mitigating sulfur mustard-induced pulmonary morbidities. Sulfur mustard, a chemical warfare agent, causes severe and long-lasting respiratory damage, underscoring the urgent need for effective countermeasures. "This CRADA represents a pivotal opportunity to leverage our Small Mobile Stem cell technology in addressing severe pulmonary complications caused by chemical exposure," said Dr. Abdulkader Rahmo, President of SMSbiotech. "We are honored to collaborate with USAMRICD to advance therapies that hold transformative potential for both public health and national security." SMSbiotech will provide updates on the advancement of this collaboration as they become available. About SMSbiotech SMSbiotech is a clinical-stage biotechnology company focused on developing innovative stem cell therapies for various diseases. The company's proprietary SMSc technology platform enables the delivery of stem cells to specific tissues and organs, where they can repair damaged cells and tissues. For more information about SMSbiotech, please visit View source version on Contacts Abdulkader RahmoPresident and 657-203-3030 Sign in to access your portfolio
Business Wire
22-04-2025
- Business
- Business Wire
SMSbiotech Establishes a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Chemical Defense
SAN MARCOS, Calif.--(BUSINESS WIRE)-- SMSbiotech, Inc. is pleased to announce the signing of a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). This is the first CRADA agreement for SMSbiotech, and it represents a significant milestone in the company's efforts to address critical military and civilian medical challenges that have existed for over a century. 'We are honored to collaborate with USAMRICD to advance therapies that hold transformative potential for both public health and national security.' Share Under this agreement, SMSbiotech and USAMRICD will conduct joint research focused on evaluating the efficacy of SMS cells in mitigating sulfur mustard-induced pulmonary morbidities. Sulfur mustard, a chemical warfare agent, causes severe and long-lasting respiratory damage, underscoring the urgent need for effective countermeasures. 'This CRADA represents a pivotal opportunity to leverage our Small Mobile Stem cell technology in addressing severe pulmonary complications caused by chemical exposure,' said Dr. Abdulkader Rahmo, President of SMSbiotech. 'We are honored to collaborate with USAMRICD to advance therapies that hold transformative potential for both public health and national security.' SMSbiotech will provide updates on the advancement of this collaboration as they become available. About SMSbiotech SMSbiotech is a clinical-stage biotechnology company focused on developing innovative stem cell therapies for various diseases. The company's proprietary SMSc technology platform enables the delivery of stem cells to specific tissues and organs, where they can repair damaged cells and tissues. For more information about SMSbiotech, please visit
Associated Press
22-04-2025
- Business
- Associated Press
SMSbiotech Establishes a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Chemical Defense
SAN MARCOS, Calif.--(BUSINESS WIRE)--Apr 22, 2025-- SMSbiotech, Inc. is pleased to announce the signing of a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). This is the first CRADA agreement for SMSbiotech, and it represents a significant milestone in the company's efforts to address critical military and civilian medical challenges that have existed for over a century. Under this agreement, SMSbiotech and USAMRICD will conduct joint research focused on evaluating the efficacy of SMS cells in mitigating sulfur mustard-induced pulmonary morbidities. Sulfur mustard, a chemical warfare agent, causes severe and long-lasting respiratory damage, underscoring the urgent need for effective countermeasures. 'This CRADA represents a pivotal opportunity to leverage our Small Mobile Stem cell technology in addressing severe pulmonary complications caused by chemical exposure,' said Dr. Abdulkader Rahmo, President of SMSbiotech. 'We are honored to collaborate with USAMRICD to advance therapies that hold transformative potential for both public health and national security.' SMSbiotech will provide updates on the advancement of this collaboration as they become available. About SMSbiotechFor more information about SMSbiotech, please visit View source version on CONTACT: Abdulkader Rahmo President and CSO [email protected] 657-203-3030 KEYWORD: NORTH AMERICA UNITED STATES IRELAND UNITED KINGDOM EUROPE CALIFORNIA INDUSTRY KEYWORD: RESEARCH CONTRACTS MILITARY STEM CELLS BIOTECHNOLOGY GOVERNMENT TECHNOLOGY HEALTH SCIENCE DEFENSE OTHER SCIENCE SOURCE: SMSbiotech, Inc. Copyright Business Wire 2025. PUB: 04/22/2025 09:17 AM/DISC: 04/22/2025 09:17 AM
